Menu

Palvella Therapeutics, Inc. (PVLA) Q3 2026 Earnings Call Transcript
📰

Palvella Therapeutics, Inc. (PVLA) Q3 2026 Earnings Call Transcript

All Articles on Seeking Alpha·9 days ago
#Qzkgh3hf
#seekingalpha#call#corporate#chief#today
Reading 0:00
15s threshold

Palvella Therapeutics, Inc. ( PVLA ) Q3 2026 Earnings Call November 5, 2026 8:30 AM EST

Company Participants

Bohan Wei - Vice President of Corporate Development & New Product Planning

Wesley Kaupinen - Founder, President, CEO & Director

Ashley Kline

Jeffrey Martini - Chief Scientific Officer

Matthew Korenberg - CFO, Corporate Secretary & Treasurer

Conference Call Participants

Joshua Schimmer - Cantor Fitzgerald & Co., Research Division

Ritu Baral - TD Cowen, Research Division

Graig Suvannavejh - Mizuho Securities USA LLC, Research Division

Annabel Samimy - Stifel, Nicolaus & Company, Incorporated, Research Division

Alethea Young

Presentation

Operator

Good day, and thank you for standing by. Welcome to the Palvella Therapeutics Third Quarter 2026 Financial Results Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.